Skip to main content
Top
Published in:

29-05-2025 | Original Article

Treatments for Sleep Disturbances in Individuals with Autism: Behavioral, Medication, and Combined Approaches

Authors: Patricia Korzekwa Hampshire, Jitka Elizarraras

Published in: Sleep and Vigilance | Issue 1/2025

Login to get access

Abstract

Individuals with Autism Spectrum Disorders are characterized by deficits in social interactions, communication, and restricted repetitive patterns of behavior (Sandberg et al. in J Autism Dev Disord 48:4250–4277, 2018). Also common are chronic sleep disturbances with a prevalence rate of 52–82% as compared to 32–50% found in neurotypical children (Hodge et al. in J Autism Dev Disord 43(4):956–963, 2014; Krakowiak et al. in J Sleep Res 17(2):197–206, 2008; Sandberg et al. in J Autism Dev Disord 48:4250–4277, 2018). A systematic review of the literature utilizing a PRISMA framework was conducted to gain a historical perspective on sleep intervention for this population. The aim of this review was to identify effective approaches to treatment, determine the level of evidence present, and identify promising pathways forward for future treatment and research. Results of the review identified three primary categories of intervention including medication-based, behavioral approaches, and combined intervention packages. Of these, behaviorally based interventions that include a parent coaching component appear to be the most effective and have the potential for long-lasting change. Limitations related to the breadth of search engines used to identify articles, balance in contributions between studies, and inclusion criteria are discussed.
Literature
This content is only visible if you are logged in and have the appropriate permissions.
Metadata
Title
Treatments for Sleep Disturbances in Individuals with Autism: Behavioral, Medication, and Combined Approaches
Authors
Patricia Korzekwa Hampshire
Jitka Elizarraras
Publication date
29-05-2025
Publisher
Springer Nature Singapore
Published in
Sleep and Vigilance / Issue 1/2025
Electronic ISSN: 2510-2265
DOI
https://doi.org/10.1007/s41782-025-00309-7

How can your team use biomarkers to improve management of AD? (Link opens in a new window)

Our experts explore using biomarker tests and interpreting results, establishing a shared decision-making approach with patients and caregivers, and applying biomarker testing to guide treatment strategies.

This content is intended for healthcare professionals outside of the UK.

Supported by:
  • Lilly
Developed by: Springer Health+ IME
Learn more